Effect of omega-3 Fatty acids in addition to Methylphenidate in ADHD
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
- Registration Number
- CTRI/2020/05/025267
- Lead Sponsor
- Government Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age of the participant between 6-12 years.
2. Children who are willing to give assent and parents/guardians of the participants are willing to give informed consent for participation.
3. School going children
4. Intelligence quotient more than 85
5. Children who have not received Methylphenidate in the past.
Exclusion Criteria
1. Children with Autism Spectrum Disorder.
2. Preexisting structural brain damage and seizures.
3. Presence co-morbid Conduct disorder, Anxiety disorder or Depressive disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of omega 3 Fatty acids as an Adjuvant Therapy to Methylphenidate in Attention Deficit Hyperactivity DisorderTimepoint: Baseline, Week 1, Week 2, Week 4, End of week 8, End of Week 12
- Secondary Outcome Measures
Name Time Method To study the efficacy of omega 3 Fatty acids as an Adjuvant Therapy to Methylphenidate in Attention Deficit Hyperactivity DisorderTimepoint: Baseline, Week 1, Week 2, Week 4, End of week 8, End of Week 12